European Federation of Pharmaceutical Industries and Associations

Tweet this page
<
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
>
Registration as it was on 31 May 2017
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

5,528,906€

Financial year: Jan 2016 - Dec 2016

Lobbyists (Full time equivalent)

15.25 Fte (29)

Lobbyists with EP accreditation

4

High-level Commission meetings

101

Lobbying Costs over the years

  • Info

    European Federation of Pharmaceutical Industries and Associations   (EFPIA)

    EU Transparency Register

    38526121292-88 First registered on 04 Mar 2009

    Goals / Remit

    EFPIA operates as the representative organisation of the pharmaceutical industry in Europe. The aim of the Associations, which has no profit-making purpose, is to promote pharmaceutical discovery and development in Europe and to bring to the market medicinal products in order to improve human health worldwide.
    In addition, EFPIA pursues a mainly scientific aim, ensuring and promoting the technological and economic development of the pharmaceutical industry in Europe.
    EFPIA's activities extend to all matters of common interest to its members. In particular, it aims to foster an environment that encourages pharmaceutical research and development, manufacture in compliance with high quality standards, intellectual property protection and the introduction of regulatory requirements to allow patients rapid access to medicinal products.

    Main EU files targeted

    Any health or pharmaceutical policy stemming from the European Institutions such as life sciences strategy, European Semester, Europe 2020 strategy, IMI, HTA policy, etc. EFPIA also follows ongoing trade negotiations and legislative files when relevant to the innovative pharmaceutical industry.

    Address

    Head Office
    8 Rue Mil Neuf Cents
    Luxembourg L-2157
    LUXEMBOURG
    EU Office
    Rue du Trone 108
    Brussels 1050
    BELGIUM
  • People

    Total lobbyists declared

    29

    Employment timeLobbyists
    100%2
    75%5
    50%16
    25%6

    Lobbyists (Full time equivalent)

    15.25

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    4 accreditations were / are live (in bold) for the selected state of 31 May 2017

    Name Start date End Date
    Ms Athina Giannoutou 20 Sep 2022 19 Sep 2023
    Ms Alexandra Tamas 06 Aug 2022 04 Aug 2023
    Ms Sophie Millar 16 Jul 2022 14 Jul 2023
    Mr Laurent David LOUETTE 25 May 2022 24 May 2023
    Ms Martina D'AMORE 31 May 2022 30 May 2023
    Ms Sibilia QUILICI 31 May 2022 30 May 2023
    Ms Anna VICERE 25 May 2022 24 May 2023
    Mr Laurent David M Louette 25 May 2022 24 May 2023
    Mr Giacomo Borgo 24 May 2022 23 May 2023
    Ms Nathalie Moll 24 May 2022 23 May 2023
    Roberta SAVLI 22 Apr 2022 21 Apr 2023
    Mr PEDRO MANUEL DIAS DE FIGUEIREDO PEREIRA MARQUES 22 Apr 2022 21 Apr 2023
    Ms Alexandra Tamas 14 Aug 2021 12 Aug 2022
    Ms Sophie Millar 24 Jul 2021 22 Jul 2022
    Mr Koen BERDEN 08 Jun 2021 07 Jun 2022
    Ms Martina D'AMORE 04 Jun 2021 03 Jun 2022
    Ms Nathalie Moll 04 Jun 2021 03 Jun 2022
    Ms Sibilia QUILICI 11 May 2021 10 May 2022
    Ms Anna VICERE 06 May 2021 05 May 2022
    Ms Elizabeth Maria KUIPER 05 May 2021 29 Apr 2022
    Mr Giacomo Borgo 05 May 2021 29 Apr 2022
    Ms Kristine PEERS 05 May 2021 29 Apr 2022
    Ms Magdalena CHLEBUS 05 May 2021 29 Apr 2022
    Mr Carlos PARRY LAFONT 29 Oct 2020 28 Oct 2021
    Mr Koen BERDEN 15 Feb 2020 28 Feb 2021
    Ms Magdalena RODRIGUEZ DE AZERO MACHADO 04 Feb 2020 03 Feb 2021
    Ms anna swierczyna 01 Feb 2020 29 Jan 2021
    Ms Lenka Christiaens 09 Jan 2020 08 Jan 2021
    Ms Kristine PEERS 05 Oct 2019 02 Oct 2020
    Ms Tea Jardas 05 Oct 2019 02 Oct 2020
    Mr Giacomo Borgo 05 Oct 2019 02 Oct 2020
    Ms Sofia MARCHA 24 Aug 2019 31 Aug 2020
    Ms Anna JEDRUSIK 22 Aug 2019 21 Aug 2020
    Ms Magdalena CHLEBUS 21 Aug 2019 31 Aug 2020
    Ms Nathalie Moll 16 Jul 2019 15 Jul 2020
    Mr Giacomo Borgo 01 Dec 2018 30 Nov 2019
    Ms Lenka Christiaens 06 Nov 2018 05 Nov 2019
    Ms Tea Jardas 06 Nov 2018 05 Nov 2019
    Ms Sofia MARCHA 12 Sep 2018 11 Sep 2019
    Ms Kristine PEERS 12 Sep 2018 11 Sep 2019
    Ms Anna JEDRUSIK 12 Sep 2018 11 Sep 2019
    Ms Ioana Enache 01 Aug 2018 31 Jul 2019
    Ms Magdalena CHLEBUS 18 Jul 2018 17 Jul 2019
    Ms Nathalie Moll 08 Jun 2018 07 Jun 2019
    Ms Gabriella Seo ALMBERG 27 Oct 2017 19 Oct 2018
    Ms Lenka Christiaens 27 Oct 2017 19 Oct 2018
    Ms Ioana Enache 31 Aug 2017 24 Aug 2018
    Ms Magda Chlebus 20 Jul 2017 05 Jul 2018
    Ms Nathalie Moll 05 May 2017 30 Apr 2018
    Ms Gabriella Seo ALMBERG 28 Oct 2016 27 Oct 2017
    Ms Raquel Silva Resendes 20 Oct 2016 18 Oct 2017
    Ms Ioana Enache 22 Aug 2016 18 Aug 2017
    Ms Magda Chlebus 19 Jan 2016 18 Jan 2017
    Mr Richard Arne BERGSTRÖM 11 Dec 2015 09 Dec 2016
    Mr Brendan Barnes 27 Nov 2015 30 Nov 2016
    Ms Elise Celia Melon 25 Nov 2015 19 Nov 2016
    Ms Gabriella Seo ALMBERG 17 Oct 2015 15 Oct 2016
    Ms Raquel Silva Resendes 17 Oct 2015 14 Oct 2016
    Ms Ioana Enache 29 Jul 2015 27 Jul 2016
    Ms Gabriella Seo ALMBERG 28 Oct 2014 23 Oct 2015
    Ms Magda Chlebus 21 Jan 2015 19 Jan 2016
    Mrs Gabriella Seo ALMBERG 28 Oct 2014 23 Oct 2015
    Mr Brendan Barnes 24 Oct 2014 22 Oct 2015
    Ms Elise Celia Melon 24 Oct 2014 22 Oct 2015
    Ms Raquel Silva Resendes 22 Oct 2014 17 Oct 2015
    Ms Anna Krózser 06 Sep 2014 04 Sep 2015
    Mr Richard Arne BERGSTRÖM 17 Jun 2014 13 Jun 2015
    Mrs Magdalena Chlebus 06 Dec 2013 04 Dec 2014
    Mrs Gabriella Seo ALMBERG 30 Oct 2013 28 Oct 2014
    Ms Raquel Silva Resendes 30 Oct 2013 28 Oct 2014
    Mr Brendan Barnes 05 Sep 2013 03 Sep 2014
    Mrs Angela Lorena PIEDRA HERNANDEZ 11 Sep 2013 09 Sep 2014
    Mr Richard Arne BERGSTRÖM 04 Jul 2013 02 Jul 2014
    Mrs Isabelle CLAMOU 04 Apr 2013 28 Mar 2014
    Mrs Isabelle CLAMOU 07 Mar 2012 31 Mar 2013
    Mrs Gabriella Seo ALMBERG 31 Jan 2013 26 Oct 2013
    Ms Raquel Silva Resendes 23 Nov 2012 26 Oct 2013
    Mrs Gabriella Seo ALMBERG 31 Jan 2012 31 Jan 2013
    Mrs Angela Lorena PIEDRA HERNANDEZ 31 Jan 2012 31 Jan 2013
    Mr Richard Arne BERGSTRÖM 30 Jan 2012 31 Jan 2013
    Isabelle CLAMOU 07 Mar 2012 31 Mar 2013

    Complementary Information

    EFPIA’s Team is constituted of 48 employees, including 4 dedicated to Vaccines Europe and 4 dedicated to EBE, both “specialised groups within EFPIA. As these groups are registered separately, staff dedicated to their activities are not included in the EFPIA reporting.
    EFPIA employees that are not (7) involved in activities within scope of the Register are not included in the number of persons. EFPIA has also not included staff spending less than 10% of their work time with EU Institutions (4).
    Numbers show the situation per 31 March 2016 for the financial year 2016.

    Person in charge of EU relations

    Ms Nathalie Moll (Director General)

    Person with legal responsibility

    Mr Joseph Jimenez (President)

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Trade and business associations

  • Networking

    Affiliation

    EFPIA’s constituent entities include:
    - 40 corporate members (companies)
    - 33 member associations (national associations)
    - 2 specialised groups: Vaccines Europe (VE) and the European Bio-Pharmaceutical Enterprises (EBE) are registered separately under n° 768792210017-73 and 53073567234-18, respectively.
    - 22 Partners in Research.

    http://www.efpia.eu/about-us/membership

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2016 - Dec 2016

    Lobbying costs for closed financial year

    5,528,906€

    Other financial info

    Grant from FP7 please see Vaccines Europe (n° 768792210017-73) – funding received during 2016 amounts to € 100.121. The project ended in 2016.

    EFPIA recommends that, along with EFPIA, each of its constituent entities – including corporate members, member associations and members of specialised groups – register in their individual capacity.

    EFPIA, has developed Guidance to its members. The Guidance aims at supporting consistent and transparent reporting among EFPIA members. EFPIA Guidance follows the provisions in the renewed Inter-institutional Agreement between the European Parliament and the EU Commission, and builds on the recommendations of the Joint Transparency Register Secretariat.

    Information included in the EFPIA Registration complies with the EFPIA Guidance. EFPIA will provide detailed information upon request.

    The EFPIA specialised groups have registered separately: EBE with public ID number 768792210017-73 and Vaccines Europe (VE) with public ID number 53073567234-18. Since specialised groups have no legal responsibility, their registration is under the legal responsibility of EFPIA. However, EBE and VE will be registered as separate “subsidiaries”, with cross-referencing links.

    Constituent entities that are not included in the EU “Transparency Register” shall not be part of EFPIA delegations interacting with the European Commission and with the European Parliament.

  • EU Structures

    Groups (European Commission)

    x
    Expert group on safe and timely access to medicines for patients (STAMP)
    Expert group on cancer control
    Expert group on the protection of animals used for scientific purposes
    Working group on chemicals
    Platform on ethics and transparency
    Platform on access to medicines
    EU Health policy forum

    ACC

    None

    Groups (European Parliament)

    None

    Other activities

    EFPIA covers regularly the committee debates in the European Parliament and attends public hearings, conferences, roundtables that are important to the industry. EFPIA also meets regularly Members of the European Parliament and assistants to facilitate the dialogue with the policy makers.
    EFPIA has also regular interaction with the European Commission services including DG GROW, DG SANTE, DG RTD, DG TRADE, DG ECFIN, DG ENV, DG DEVCO and DG JUST, etc.

  • Meetings

    Meetings

    101 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't publish information about such meetings. All information below comes from European Commission web pages.

    • Date 17 Oct 2022 Location Virtual
      Subject EFPIA/EC catch-up on HERA Next meeting of the Joint Cooperation Industrial Forum
      Commission
      • Pierre Delsaux (Director-General)
    • Date 10 Oct 2022 Location Brussels (WEBEX)
      Subject Conc. Commission proposals to revise the entire EU pharmaceutical legislation by the end of the year
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Commission
      • Kurt Vandenberghe (Cabinet member)
    • Date 29 Jun 2022 Location Brussels
      Subject Pharma Strategy
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Commission
      • Margaritis Schinas (Vice-President)
      • Maria Luisa Llano Cardenal (Cabinet member)
    • Date 29 Jun 2022 Location Brussels
      Subject Exchange of views on the upcoming pharmaceutical legislation
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Stella Kyriakides (Commissioner)
    • Date 11 May 2022 Location on-line meeting
      Subject Exchange of views on the upcoming pharmaceutical strategy.
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Giorgios Rossides (Cabinet member)
      • Karolina Herbout-Borczak (Cabinet member)
    • Date 06 May 2022 Location Online
      Subject European Health Data Space, Data Act, Data Governance Act
      Cabinet Cabinet of Executive Vice-President Margrethe Vestager
      Portfolio Europe Fit for Digital Age
      Commission
      • Werner Stengg (Cabinet member)
    • Date 29 Mar 2022 Location online meeting
      Subject access to medicines online portal
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Commission
      • Despina Spanou (Cabinet member)
      • Maria Luisa Llano Cardenal (Cabinet member)
    • Date 16 Mar 2022 Location Brussels (virtual via Webex)
      Subject  EU Pharmaceutical Strategy
      Commission
      • Sandra Gallina (Director-General)
    • Date 26 Oct 2021 Location Brussels
      Subject Pharmaceutical sector – trade related issues
      Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis
      Portfolio An Economy that Works for People
      Commission
      • Kevin Keary (Cabinet member)
      • Caroline Boeshertz (Cabinet member)
      • Elina Melngaile (Cabinet member)
      Other Lobbyists
    • Date 21 Jun 2021 Location Brussels
      Subject Pharmaceutical strategy
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Commission
      • Maria Luisa Llano Cardenal (Cabinet member)
      • Margaritis Schinas (Vice-President)
    • Date 16 Jun 2021 Location online
      Subject Supply chains for medicines
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Commission
      • Maria Luisa Llano Cardenal (Cabinet member)
      • Margaritis Schinas (Vice-President)
      Other Lobbyists
    • Date 07 Jun 2021 Location Brussels
      Subject VTC meeting - Access to Medicines
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 17 May 2021 Location Video conferencing
      Subject EU vaccine policy
      Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis
      Portfolio An Economy that Works for People
      Commission
      • Caroline Boeshertz (Cabinet member)
      • Cristina Rueda Catry (Cabinet member)
      • Michael Hager (Cabinet member)
    • Date 08 Apr 2021 Location online
      Subject Health Union
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Commission
      • Margaritis Schinas (Vice-President)
      • Catherine Sustek (Cabinet member)
      Other Lobbyists
    • Date 25 Mar 2021 Location virtual meeting
      Subject Biopharmaceutical CEO Roundtable
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Commission
      • Maria Luisa Llano Cardenal (Cabinet member)
      • Despina Spanou (Cabinet member)
    • Date 05 Mar 2021 Location Brussels
      Subject VC Meeting discussion on COVID-19 vaccines export authorisation scheme.
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 12 Feb 2021 Location Brussels (virtual)
      Subject Phone call with EFPIA
      Commission
      • Sandra Gallina (Director-General)
    • Date 06 Nov 2020 Location Brussels - virtual
      Subject Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 23 Oct 2020 Location VTC
      Subject Stronger “European health union”
      Cabinet Cabinet of Commissioner Olivér Várhelyi
      Portfolio Neighbourhood and Enlargement
      Commission
      • Szabolcs Horvath (Cabinet member)
    • Date 22 Oct 2020 Location Brussels (Webex)
      Subject Exchange of views on the upcoming pharmaceutical strategy
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Karolina Herbout-Borczak (Cabinet member)
      • Giorgios Rossides (Cabinet member)
      Other Lobbyists
    • Date 20 Oct 2020 Location Virtual meeting
      Subject Pharmaceutical strategy
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Commission
      • Despina Spanou (Cabinet member)
      • Maria Luisa Llano Cardenal (Cabinet member)
    • Date 15 Oct 2020 Location Online meeting
      Subject Conference on the Future of Europe Health and industrial policies
      Cabinet Cabinet of Vice-President Dubravka Šuica
      Portfolio Democracy and Demography
      Commission
      • Astrid Dentler (Cabinet member)
      • Mattia De Grassi (Cabinet member)
    • Date 06 Oct 2020 Location Brussels
      Subject Pharmaceuticals strategy, Industrial strategy and trade policy issues
      Cabinet Cabinet of Executive Vice-President Margrethe Vestager
      Portfolio Europe Fit for Digital Age
      Commission
      • Nele Eichhorn (Cabinet member)
    • Date 23 Sep 2020 Location Brussels (video conference)
      Subject EU pharmaceutical strategy and the general approach to IP in pharmaceuticals
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Commission
      • Kurt Vandenberghe (Cabinet member)
    • Date 18 Sep 2020 Location Videoconference
      Subject Pharmaceutical strategy
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Commission
      • Eszter Batta (Cabinet member)
    • Date 03 Jul 2020 Location Brussels
      Subject VC meeting : Exchange of views on the forthcoming Pharmaceutical Strategy
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Stella Kyriakides (Commissioner)
    • Date 29 Jun 2020 Location Brussels
      Subject Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 10 Jun 2020 Location Brussels
      Subject Webex meeting upon EFPIA’s request to discuss the forthcoming Pharmaceutical Strategy, the evaluation of the EU Orphan Medicinal Products and Paediatrics regulations and the proposed HTA regulation
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Karolina Herbout-Borczak (Cabinet member)
      • Giorgios Rossides (Cabinet member)
    • Date 08 Jun 2020 Location Videoconference
      Subject Exchange of views on the new pharmaceutical strategy for Europe
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Commission
      • Despina Spanou (Cabinet member)
      • Maria Luisa Llano Cardenal (Cabinet member)
    • Date 05 Jun 2020 Location Brussels (virtual meeting)
      Subject pharmaceutical strategy of the Commission, SWD on the Orphan and Paediatric Regulation
      Commission
      • Anne Bucher (Director-General)
    • Date 29 May 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 19 May 2020 Location Videomeeting
      Subject To discuss EU Pharmaceutical Strategy and EU Chemical Strategy and cooperation on green agenda.
      Cabinet Cabinet of Commissioner Virginijus Sinkevičius
      Portfolio Environment, Oceans and Fisheries
      Commission
      • Camilla Bursi (Cabinet member)
      • Virginijus Sinkevičius (Commissioner)
    • Date 15 May 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 08 May 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 08 May 2020 Location Videoconference
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Commission
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 05 May 2020 Location Phone call
      Subject courtesy call and presentation by EFPIA of their concerns due to COVID crisis and the future of pharmaceutical industry
      Commission
      • Kerstin Jorna (Director-General)
    • Date 29 Apr 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 29 Apr 2020 Location Videconference
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Commission
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 24 Apr 2020 Location Brussels
      Subject Covid-19
      Commission
      • Jean-Eric Paquet (Director-General)
    • Date 23 Apr 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 23 Apr 2020 Location Videconference
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Commission
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 17 Apr 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 09 Apr 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 09 Apr 2020 Location Videoconference
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Commission
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 03 Apr 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 03 Apr 2020 Location Videoconference
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Commission
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 02 Apr 2020 Location Brussels (phone call)
      Subject update on Pharma Strategy
      Commission
      • Anne Bucher (Director-General)
    • Date 27 Mar 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 27 Mar 2020 Location Videoconference
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Commission
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 20 Mar 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 20 Mar 2020 Location Videoconference
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Commission
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 13 Mar 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 28 Feb 2020 Location Brussels
      Subject EFPIA requested a meeting to present their ongoing work
      Cabinet Cabinet of Commissioner Jutta Urpilainen
      Portfolio International Partnerships
      Commission
      • Renaud Savignat (Cabinet member)
    • Date 11 Feb 2020 Location Brussels, Belgium
      Subject Health In humanitarian aid and in crisis management
      Cabinet Cabinet of Commissioner Janez Lenarčič
      Portfolio Crisis Management
      Commission
      • Kasia Jurczak (Cabinet member)
    • Date 11 Feb 2020 Location Brussels, Belgium
      Subject Pharmaceutical strategy
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Commission
      • Olympia Neocleous (Cabinet member)
    • Date 06 Feb 2020 Location Brussels
      Subject Medical innovation & Reform policies
      Cabinet Cabinet of Commissioner Elisa Ferreira
      Portfolio Cohesion and Reforms
      Commission
      • Marlene Madsen (Cabinet member)
    • Date 23 Jan 2020 Location Brussels
      Subject Integrated health solutions, active ageing, sustainability and quality of healthcare systems, long-term visions on healthcare
      Cabinet Cabinet of Vice-President Dubravka Šuica
      Portfolio Democracy and Demography
      Commission
      • Astrid Dentler (Cabinet member)
    • Date 23 Jan 2020 Location Brussels
      Subject presentation EFPIA's manifesto
      Cabinet Cabinet of Commissioner Phil Hogan
      Commission
      • Dermot Ryan (Cabinet member)
    • Date 29 Aug 2019 Location Brussels
      Subject EFPIA position on the EU preliminary list of US products considered for countermeasures
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Commission
      • Arunas Ribokas (Cabinet member)
    • Date 29 Aug 2019 Location Brussels
      Subject Trade in the pharma sector
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Commission
      • Miguel Ceballos Baron (Cabinet member)
    • Date 23 Jul 2019 Location BREY-Brussels
      Subject Present their latest Manifesto and introduce the pharmaceutical companies position towards new Commission
      Commission
      • Timo Pesonen (Acting Director-General)
    • Date 26 Jun 2019 Location Brussels
      Subject Access to medicines, shortages, medicines for rare diseases and children
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Commission
      • Alina Timofte (Cabinet member)
      • Vytenis Andriukaitis (Commissioner)
      • Arunas Vinciunas (Cabinet member)
    • Date 25 Jun 2019 Location Brussels
      Subject development of a High-level Forum on Healthcare; the Commission "outcomes" agenda; EU HTA Regulation proposal
      Commission
      • Anne Bucher (Director-General)
    • Date 23 Apr 2019 Location BRUSSELS
      Subject PPPs in health area
      Commission
      • Jean-Eric Paquet (Director-General)
    • Date 04 Feb 2019 Location Brussels
      Subject Supplementary Protection Certificate Manufacturing Waiver in Europe and EFPIA’s priorities in the context of the 2019 institutional changes
      Cabinet Cabinet of Vice-President Jyrki Katainen
      Portfolio Jobs, Growth, Investment and Competitiveness
      Commission
      • Jyrki Katainen (Vice-President)
    • Date 03 Dec 2018 Location Brussels, Belgium
      Subject courtesy visit
      Commission
      • Anne Bucher (Director-General)
    • Date 07 Sep 2018 Location Brussels
      Subject Partnesrhips
      Commission
      • Jean-Eric Paquet (Director-General)
    • Date 15 Jun 2018 Location Brussels, Berl
      Subject HTA
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Commission
      • Vytenis Andriukaitis (Commissioner)
      • Annika Nowak (Cabinet member)
      Other Lobbyists
    • Date 19 Apr 2018 Location Brussels
      Subject Competitiveness of the European Pharmaceutical industry
      Cabinet Cabinet of Vice-President Jyrki Katainen
      Portfolio Jobs, Growth, Investment and Competitiveness
      Commission
      • Risto Artjoki (Cabinet member)
    • Date 21 Mar 2018 Location Brussels
      Subject competitiveness of the life science industry in Europe
      Cabinet Cabinet of Vice-President Günther Oettinger
      Portfolio Budget &amp; Human Resources
      Commission
      • Michael Hager (Cabinet member)
    • Date 19 Mar 2018 Location Brussels
      Subject Health in development cooperation
      Cabinet Cabinet of Vice-President Neven Mimica
      Portfolio International Cooperation &amp; Development
      Commission
      • Nils Behrndt (Cabinet member)
    • Date 15 Mar 2018 Location Brussels
      Subject Research & Innovation policy
      Cabinet Cabinet of Commissioner Tibor Navracsics
      Portfolio Education, Culture, Youth and Sport
      Commission
      • Patricia Reilly (Cabinet member)
    • Date 08 Feb 2018 Location Brussels
      Subject Possible change of EU patent legislation
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Commission
      • Nele Eichhorn (Cabinet member)
      • Maria Asenius (Cabinet member)
    • Date 30 Jan 2018 Location Brussels
      Subject Exchange of views on current topics
      Cabinet Cabinet of Commissioner Elżbieta Bieńkowska
      Portfolio Internal Market, Industry, Entrepreneurship and SMEs
      Commission
      • Fabrice Comptour (Cabinet member)
      • Elżbieta Bieńkowska (Commissioner)
    • Date 17 Jan 2018 Location Brussels
      Subject Role of pharmaceutical industry in development cooperation
      Cabinet Cabinet of Vice-President Neven Mimica
      Portfolio International Cooperation &amp; Development
      Commission
      • Irena Andrassy (Cabinet member)
      • Nils Behrndt (Cabinet member)
    • Date 12 Jan 2018 Location Brussels
      Subject Discussion on AMR
      Commission
      • Xavier Prats Monné (Director-General)
    • Date 15 Dec 2017 Location BRUSSELS
      Subject AMR; Pharma
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Commission
      • Annika Nowak (Cabinet member)
    • Date 29 Nov 2017 Location Brussels
      Subject Pharmaceutical incentives, antimicrobial resistance
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Commission
      • Annika Nowak (Cabinet member)
      • Vytenis Andriukaitis (Commissioner)
      Other Lobbyists
    • Date 27 Oct 2017 Location BRUSSELS
      Subject Meeting with the Task Force for the Preparation and Conduct of the Negotiations with the United Kingdom under Article 50 TEU
      Commission
      • Michel Barnier (Head of Task Force)
      Other Lobbyists
    • Date 29 Jun 2017 Location Brussels
      Subject Turkey - in breach of rules; Canada - some concerns around implementing legislation.
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Commission
      • Maria Asenius (Cabinet member)
      • Christian Burgsmueller (Cabinet member)
    • Date 24 Apr 2017 Location Brussels
      Subject Follow-up to COUNCIL conclusions: Impact of the incentives on innovation, availability and accessibility of medicinal products
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Commission
      • Annika Nowak (Cabinet member)
    • Date 31 Jan 2017 Location Brussels
      Subject Non Communicable diseases
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Commission
      • Annika Nowak (Cabinet member)
    • Date 07 Dec 2016 Location Brussels
      Subject Meeting with EPFIA'S President, IMI/Innovation Policy
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      Commission
      • Carlos Moedas (Commissioner)
      • Giulia Del Brenna (Cabinet member)
    • Date 07 Oct 2016 Location Brussels, Belgium
      Subject GDPR
      Cabinet Cabinet of Commissioner Věra Jourová
      Portfolio Justice, Consumers and Gender Equality
      Commission
      • Kevin O'Connell (Cabinet member)
    • Date 15 Jun 2016 Location Brussels
      Subject HTA, AMR, Access to innovative medicines
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Commission
      • Annika Nowak (Cabinet member)
      • Vytenis Andriukaitis (Commissioner)
    • Date 03 Jun 2016 Location Brussels
      Subject AMR, Situation in Ukraine
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Commission
      • Annika Nowak (Cabinet member)
      • Vytenis Andriukaitis (Commissioner)
    • Date 24 Feb 2016 Location Brussels
      Subject TTIP, CETA, affordable medicines
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Commission
      • Cecilia Malmström (Commissioner)
    • Date 24 Feb 2016 Location Brussels
      Subject Access to Medicines, HTA, AMR
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Commission
      • Vytenis Andriukaitis (Commissioner)
      • Annika Nowak (Cabinet member)
    • Date 24 Feb 2016 Location Brussels
      Subject Big Data, ehealth
      Commission
      • Günther Oettinger (Commissioner)
    • Date 23 Feb 2016 Location Brussels, Belgium
      Subject Access to health care and pharmaceuticals in developing countries
      Cabinet Cabinet of Vice-President Neven Mimica
      Portfolio International Cooperation &amp; Development
      Commission
      • Nils Behrndt (Cabinet member)
    • Date 25 Nov 2015 Location Brussels
      Subject AMR
      Commission
      • Xavier Prats Monné (Director-General)
    • Date 19 Nov 2015 Location Brussels
      Subject TTIP
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Commission
      • Miguel Ceballos Baron (Cabinet member)
      • Maria Asenius (Cabinet member)
      Other Lobbyists
    • Date 28 May 2015 Location Brussels, Belgium
      Subject Developments of pharmaceutical industry
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Commission
      • Arunas Vinciunas (Cabinet member)
    • Date 22 Apr 2015 Location Brussels
      Subject Trade relations with US and China
      Commission
      • Jean-Luc Demarty (Director-General)
    • Date 25 Feb 2015 Location Brussels
      Subject Trade negotiations and health
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Commission
      • Cécile Billaux (Cabinet member)
    • Date 10 Feb 2015 Location Brussels
      Subject Science and innovation
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      Commission
      • Antonio Lowndes Marques De Araujo Vicente (Cabinet member)
    • Date 10 Feb 2015 Location Brussels
      Subject TTIP
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Commission
      • Maria Asenius (Cabinet member)
      • Miguel Ceballos Baron (Cabinet member)
    • Date 26 Jan 2015 Location Brussels, Belgium
      Subject Anti-biotic resistance within development policy
      Cabinet Cabinet of Vice-President Neven Mimica
      Portfolio International Cooperation &amp; Development
      Commission
      • Paolo Berizzi (Cabinet member)
    • Date 23 Jan 2015 Location Brussels, Belgium
      Subject EFPIA engagement in developing countries
      Cabinet Cabinet of Vice-President Neven Mimica
      Portfolio International Cooperation &amp; Development
      Commission
      • Nils Behrndt (Cabinet member)
    • Date 19 Dec 2014 Location Brussels
      Subject Innovative Medecines Initiative / Ebola crisis
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      Commission
      • Giulia Del Brenna (Cabinet member)
    • Date 18 Dec 2014 Location Brussels
      Subject European industry’s perspective on the future of EU research and innovation policy
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      Commission
      • Carlos Moedas (Commissioner)
Download this datacard